VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 50 filers reported holding VOR BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,023 | -64.1% | 52,841 | -47.7% | 0.00% | – |
| Q2 2023 | $312,427 | -82.5% | 101,109 | -69.5% | 0.00% | – |
| Q1 2023 | $1,780,581 | +459.0% | 330,963 | +591.0% | 0.00% | – |
| Q4 2022 | $318,515 | +20.6% | 47,897 | -9.8% | 0.00% | – |
| Q2 2022 | $264,000 | -8.3% | 53,074 | +114.7% | 0.00% | – |
| Q4 2021 | $288,000 | – | 24,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,692,429 | $288,444,000 | 51.94% |
| Trustees of Columbia University in the City of New York | 183,821 | $7,923,000 | 9.60% |
| RA Capital Management | 11,120,973 | $479,314,000 | 7.23% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $46,318,000 | 6.00% |
| Sarissa Capital Management LP | 707,010 | $30,472,000 | 2.92% |
| SECTORAL ASSET MANAGEMENT INC | 535,259 | $23,070,000 | 1.75% |
| Woodline Partners LP | 1,153,267 | $49,706,000 | 1.10% |
| Artal Group S.A. | 550,000 | $23,705,000 | 0.42% |
| Orbimed Advisors | 833,333 | $35,917,000 | 0.34% |
| Laurion Capital Management LP | 585,667 | $25,242,000 | 0.14% |